BBSRC Portfolio Analyser
Award details
Identification of protective Chalmydia antigens using a novel technology
Reference
BB/J010855/1
Principal Investigator / Supervisor
Dr Adrian Smith
Co-Investigators /
Co-Supervisors
Institution
University of Oxford
Department
Zoology
Funding type
Research
Value (£)
156,608
Status
Completed
Type
Research Grant
Start date
01/12/2012
End date
28/02/2014
Duration
15 months
Abstract
unavailable
Summary
BBSRC funded research led to the discovery of a unique approach to identify antigens that confer protective immunity. This approach, known as Protecta Antigen Finding (PAF) allows discrimination of pathogen-derived antigens that mediate protection from the larger cohort that simply stimulate a response. PAF has stimulated significant interest within the vaccine industry, Seed Fund and Venture Capital sectors. To realise the commercial potential of PAF we have demonstrated PAF utility in vaginal Chlamydia infection. The key objective of this FOF application is to perform the next phase of PAF and identify the antigens that afford protection. A panel of new protective antigens against Chlamydia will provide a foundation for commercial exploitation via spin-out and/or licensing routes. The PAF project has a solid IP platform and has attracted a small amount of seed funding and developed a robust commercial and technical plan necessary to succeed in this competitive and high impact arena.
Committee
Not funded via Committee
Research Topics
Immunology, Pharmaceuticals
Research Priority
X – Research Priority information not available
Research Initiative
Follow-On Fund (FOF) [2004-2015]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search